Natera, Inc. Common Stock (NTRA) is a publicly traded Healthcare sector company. As of July 5, 2026, NTRA trades at $279.32 with a market cap of $40.00B and a P/E ratio of -183.76. NTRA moved +1.14% today. Year to date, NTRA is +21.45%; over the trailing twelve months it is +72.88%. Its 52-week range spans $125.38 to $279.63. Analyst consensus is strong buy with an average price target of $266.93. Rallies surfaces NTRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for NTRA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $279.32 |
| Market Cap | $40.00B |
| P/E Ratio | -183.76 |
| EPS | $-1.52 |
| Dividend Yield | 0.00% |
| 52-Week High | $279.63 |
| 52-Week Low | $125.38 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.31B |
| Net Income | $-208.16M |
| Gross Margin | 0.00% |
18 analysts cover NTRA: 0 strong buy, 16 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $266.93.